Towards delivering truly personalised therapy for oesophageal cancer

Prof Tim Underwood - University of Southampton, Southampton, UK
Towards delivering truly personalised therapy for oesophageal cancer ( Prof Tim Underwood - University of Southampton, Southampton, UK )
23 Nov 2016

Lipomodelling of stoma

Riccardo Bonomi - Western Sussex Hospital Foundation Trust, Worthing, UK
Lipomodelling of stoma ( Riccardo Bonomi - Western Sussex Hospital Foundation Trust, Worthing, UK )
23 Nov 2016

Non surgical treatment of rectal cancer

Prof Arthur Sun Myint - Clatterbridge Centre for Oncology NHS Foundation Trust, Birkenhead, UK
Non surgical treatment of rectal cancer ( Prof Arthur Sun Myint - Clatterbridge Centre for Oncology NHS Foundation Trust, Birkenhead, UK )
23 Nov 2016

GI and gynaecological tumours in the elderly

Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus
GI and gynaecological tumours in the elderly ( Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus )
22 Nov 2016

What are the successes of SIOG?

Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus
What are the successes of SIOG? ( Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus )
22 Nov 2016

Carcinoid syndrome

Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
Carcinoid syndrome ( Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
12 Oct 2016

LUME study of nintedanib finds improved PFS, but no overall survival boost

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
LUME study of nintedanib finds improved PFS, but no overall survival boost ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
12 Oct 2016

Left versus right sided GI tumour response in the CRYSTAL trial

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
Left versus right sided GI tumour response in the CRYSTAL trial ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
10 Oct 2016

Looking for new pathways in colorectal cancer

Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark
Looking for new pathways in colorectal cancer ( Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark )
10 Oct 2016

Olaparib and paclitaxel for 2nd line gastric cancer therapy

Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea
Olaparib and paclitaxel for 2nd line gastric cancer therapy ( Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea )
10 Oct 2016

Innovative uses of kinase inhibitors in cancer

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1)

Dr Arndt Stahler - University of Munich, Munich, Germany
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1) ( Dr Arndt Stahler - University of Munich, Munich, Germany )
9 Oct 2016